Cargando…
2427: Metabo-therapy for RARRES1-depleted epithelial cells using repurposed mitochondrial metabolism inhibitor, metformin
OBJECTIVES/SPECIFIC AIMS: The goal of this study is to examine bioenergetic phenotype of retinoic acid receptor responder 1 (RARRES1)-depleted epithelial cells and to facilitate the discovery of personalized metabo-therapeutics in the context of cancers characterized with loss of or low expression o...
Autores principales: | Maimouni, Sara, Lee, Mi-Hye, Byers, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799745/ http://dx.doi.org/10.1017/cts.2017.49 |
Ejemplares similares
-
2261 Tumor suppressor RARRES1 regulates cell survival by modulating mitochondrial energetics
por: Maimouni, Sara, et al.
Publicado: (2018) -
Tumor suppressor RARRES1- A novel regulator of fatty acid metabolism in epithelial cells
por: Maimouni, Sara, et al.
Publicado: (2018) -
Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival
por: Maimouni, Sara, et al.
Publicado: (2019) -
Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival
por: Maimouni, Sara, et al.
Publicado: (2021) -
MetaboLab - advanced NMR data processing and analysis for metabolomics
por: Ludwig, Christian, et al.
Publicado: (2011)